Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer

被引:4
作者
Rodriguez, Cesar A. [1 ]
Martin, Teresa [1 ]
Lozano, Rebeca [1 ]
Gomez, Amalia [1 ]
Cruz, Juan J. [1 ]
机构
[1] Hosp Univ Salamanca IBSAL, Dept Med Oncol, Salamanca, Spain
关键词
bevacizumab; breast cancer; nasal septum perforation; SEPTUM PERFORATION; PACLITAXEL; THERAPY; TRIAL;
D O I
10.1111/tbj.12913
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nasal septum perforation in patients with cancer receiving systemic therapy is rare, and its association with bevacizumab use has described recently in the literature. Here, we report the case of a 34-year-old woman with hormone-sensitive, HER-2/neu negative, metastatic breast cancer who develope a nasal septum perforation during the treatment with paclitaxel and bevacizumab.
引用
收藏
页码:745 / 746
页数:2
相关论文
共 50 条
[21]   Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis [J].
Di Salvatore, M. ;
Lo Giudice, L. ;
Rossi, E. ;
Santonocito, C. ;
Nazzicone, G. ;
Rodriquenz, M. G. ;
Cappuccio, S. ;
Inno, A. ;
Fuso, P. ;
Orlandi, A. ;
Strippoli, A. ;
Capoluongo, E. ;
Astone, A. ;
Cassano, A. ;
Barone, C. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (01) :40-46
[22]   Gastric Perforation Presenting as Empyema in a Patient with Pancreatic Cancer on Bevacizumab Treatment [J].
Shao, Yu-Yun ;
Lin, Zhong-Zhe ;
Liang, Po-Chin ;
Tien, Yu-Wen ;
Cheng, Ann-Lii .
ANTICANCER RESEARCH, 2009, 29 (05) :1665-1667
[23]   Tolerability of bevacizumab in elderly patients with "triple-negative" metastatic breast cancer [J].
Mocerino, C. ;
Letizia, A. ;
Taddeo, M. ;
Gambardella, A. .
GIORNALE DI GERONTOLOGIA, 2012, 60 (03) :149-153
[24]   Speckle-Tracking Echocardiography for Cardioncological Evaluation in Bevacizumab-Treated Colorectal Cancer Patients [J].
Sonaglioni, Andrea ;
Albini, Adriana ;
Fossile, Emanuela ;
Pessi, Maria Adelaide ;
Nicolosi, Gian Luigi ;
Lombardo, Michele ;
Anza, Claudio ;
Ambrosio, Giuseppe .
CARDIOVASCULAR TOXICOLOGY, 2020, 20 (06) :581-592
[25]   Pyopneumothorax during bevacizumab-containing chemotherapy in a patient with metastatic breast cancer [J].
Noriko Goda ;
Yoshiharu Kawabuchi ;
Masanobu Watari ;
Takashi Kumada ;
Tomohiro Kondo ;
Satoshi Inoue ;
Takuro Yamaguchi ;
Yuta Kuroo ;
Atsushi Nakamitsu .
International Cancer Conference Journal, 2016, 5 (1) :40-44
[26]   Pyopneumothorax during bevacizumab-containing chemotherapy in a patient with metastatic breast cancer [J].
Goda, Noriko ;
Kawabuchi, Yoshiharu ;
Watari, Masanobu ;
Kumada, Takashi ;
Kondo, Tomohiro ;
Inoue, Satoshi ;
Yamaguchi, Takuro ;
Kuroo, Yuta ;
Nakamitsu, Atsushi .
INTERNATIONAL CANCER CONFERENCE JOURNAL, 2016, 5 (01) :40-44
[27]   An observational study of nasal cavity toxicity in cancer patients treated with bevacizumab [J].
D'Amico, Mauro ;
Pagano, Mauro ;
Pasa, Ambra ;
Puntoni, Matteo ;
Clavarezza, Matteo ;
Gennari, Alessandra ;
Gozza, Alberto ;
Zanardi, Silvia ;
Defferrari, Carlotta ;
Provinciali, Nicoletta ;
Campazzi, Eleonora ;
Campora, Sara ;
Paleari, Laura ;
Marra, Domenico ;
Petrera, Marilena ;
DeCensi, Andrea .
EXPERT OPINION ON DRUG SAFETY, 2014, 13 (11) :1437-1442
[28]   Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer [J].
Sasaki, Akinori ;
Harano, Kenichi ;
Kogawa, Takahiro ;
Matsubara, Nobuaki ;
Naito, Yoichi ;
Hosono, Ako ;
Mukai, Hirofumi ;
Yoshino, Takayuki ;
Mukohara, Toru .
CASE REPORTS IN ONCOLOGICAL MEDICINE, 2020, 2020
[29]   Bevacizumab-induced small bowel perforation in a patient with breast cancer without intraabdominal metastases [J].
Edouard Lecarpentier ;
Lamia Ouaffi ;
Olivier Mir ;
Paul Berveiller ;
Melinda Maurel ;
Eric Pujade-Lauraine ;
Jean Luc Bouillot ;
Nicolas Veyrie .
Investigational New Drugs, 2011, 29 :1500-1503
[30]   Bevacizumab-induced small bowel perforation in a patient with breast cancer without intraabdominal metastases [J].
Lecarpentier, Edouard ;
Ouaffi, Lamia ;
Mir, Olivier ;
Berveiller, Paul ;
Maurel, Melinda ;
Pujade-Lauraine, Eric ;
Bouillot, Jean Luc ;
Veyrie, Nicolas .
INVESTIGATIONAL NEW DRUGS, 2011, 29 (06) :1500-1503